Idiopathic intracranial hypertension 25161 222934504 2008-07-01T20:26:09Z Jfdwolff 46555 Reverted edits by [[Special:Contributions/71.195.218.109|71.195.218.109]] ([[User talk:71.195.218.109|talk]]) to last version by Arcadian {{Mergefrom|Pediatric pseudotumor cerebri|date=June 2008}} {{DiseaseDisorder infobox | Name = Benign intracranial hypertension | ICD10 = {{ICD10|G|93|2|g|90}} | ICD9 = {{ICD9|348.2}} | Image = | Caption = | ICDO = | OMIM = 243200 | DiseasesDB = 1331 | MedlinePlus = 000351 | eMedicineSubj = neuro | eMedicineTopic = 329 | eMedicine_mult = {{eMedicine2|oph|190}} {{eMedicine2|neuro|537}} | MeshID = D011559 | }} '''Idiopathic intracranial hypertension''' (IIH), sometimes called '''benign intracranial hypertension''' (BIH) or '''pseudotumor cerebri''' (PTC) is a [[neurological disorder]] that is characterized by increased [[intracranial pressure]] (ICP), in the absence of a tumor or other diseases affecting the brain or its [[meninges|lining]]. The main symptoms are [[headache]] and visual problems. Diagnosis requires [[neuroimaging|brain scans]] and [[lumbar puncture]]. There are various medical and surgical treatments. ==Terminology== The terms "benign" and "pseudotumor" derive from the fact that increased intracranial pressure was, especially in the era before [[computed tomography]] (CT), associated with [[brain tumor]]s. Those patients in whom no tumour was found were therefore diagnosed with "pseudotumor cerebri" (a disease mimicking a brain tumor). The disease was renamed "benign intracranial hypertension" to distinguish it from intracranial hypertension due to malignancy (i.e. cancer); this was also felt to be misleading, and the name was therefore revised to "idiopathic (of no identifiable cause) intracranial hypertension".<ref>{{cite journal |author=Bandyopadhyay S |title=Pseudotumor cerebri |journal=Arch. Neurol. |volume=58 |issue=10 |pages=1699–701 |year=2001 |pmid=11594936| doi = 10.1001/archneur.58.10.1699 <!--Retrieved from CrossRef by DOI bot-->}}</ref> Raised ICP due to another cause (e.g. [[meningitis]], tumor) can be classified as "secondary intracranial hypertension". ==Signs and symptoms== Characteristic features of IIH are headache (worse in the morning, associated with nausea) and vision problems, such as [[diplopia|double vision]], transient visual obscurations, loss of peripheral sight or blurring of vision. If untreated, complete loss of vision is possible. While IIH may develop in any age group and in both males and females, it is more likely in females of fertile age (15-45) who are [[obesity|overweight or obese]]. Certain medications ([[hormonal contraception]], [[vitamin A]],<ref>{{cite journal |author=Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD |title=Serum vitamin A concentration is elevated in idiopathic intracranial hypertension |journal=Neurology |volume=53 |issue=5 |pages=1114–8 |year=1999 |pmid=10496276 |doi=}}</ref> [[tetracycline antibiotic]]s) may increase risk of IIH.<ref name=FriedmanJacobson2002>{{cite journal | last = Friedman | first = DI | coauthors = Jacobson DM | year=2002 | title = Diagnostic criteria for idiopathic intracranial hypertension | journal = Neurology | volume = 59 | issue = 10 | pages = 1492–1495 | pmid = 12455560 | url =}}</ref> Physical findings in IIH are characterized by [[papilledema]], loss of visual acuity and [[visual field]]s, and absence of focal neurological findings (e.g. face, arm or leg weakness, sensory disturbance or coordination loss). Diplopia (double vision), if present, may be due to [[abducens nerve]] palsy (the sixth [[cranial nerve]]).<ref name=FriedmanJacobson2002/> Absence of papilledema, while making IIH less likely, is possible.<ref>{{cite journal |author=Marcelis J, Silberstein SD |title=Idiopathic intracranial hypertension without papilledema |journal=Arch. Neurol. |volume=48 |issue=4 |pages=392–9 |year=1991 |pmid=2012512 |url=http://archneur.ama-assn.org/cgi/content/abstract/48/4/392 |doi=10.1001/archneur.48.4.392 |doi_brokendate=2008-06-25}}</ref> ==Diagnosis== The diagnosis may be suspected on the basis of the history and examination. To confirm the diagnosis, as well as excluding alternative causes (such as a [[brain tumor]]), several investigations are required; more investigations may be performed if the history is not typical or the patient is more likely to have an alternative problem (e.g. children, the elderly).<ref name=FriedmanJacobson2002/> [[Neuroimaging]], usually with [[computed tomography]] (CT/CAT) or [[magnetic resonance imaging]] (MRI), rules out mass lesions. In IIH these scans may be normal, although small or slit-like [[ventricular system|ventricles]] and "[[Empty sella syndrome|empty sella sign]]" (flattening of the [[pituitary gland]] due to increased pressure) may be seen. Some propose MRI as preferred mode of imaging in atypical cases, and suggest performance of MR venography to exclude venous obstruction or [[cerebral venous sinus thrombosis]].<ref name=FriedmanJacobson2002/> Once a mass lesion has been ruled out, [[lumbar puncture]] is generally performed to measure the opening pressure, as well as to obtain [[cerebrospinal fluid]] to exclude alternative diagnoses such as low-grade viral [[meningitis]]. If the opening pressure is increased, CSF may be removed for relief (see below).<ref name=FriedmanJacobson2002/> ==Criteria== The original criteria for IIH were described by [[Walter Dandy|Dandy]] in 1937.<ref name=Dandy1937>{{cite journal |author=Dandy WE|year=1937 |month=Oct |title=Intracranial pressure without brain tumor - diagnosis and treatment |journal= Ann Surg |volume=106 |issue= 4|pages=492–513 |id= |url=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1390605 | doi = 10.1097/00000658-193710000-00002 <!--Retrieved from CrossRef by DOI bot--> |pmid=17857053}}</ref> They were modified by Smith in 1985 to become the "modified Dandy criteria".<ref name=JLSmith>{{cite journal |author=Smith JL |title=Whence pseudotumor cerebri? |journal=Journal of clinical neuro-ophthalmology |volume=5 |issue=1 |pages=55–6 |year=1985 |pmid=3156890 |doi=}}</ref> {| border="1" align="center" style="text-align: center; background: #FFFFFF;" |+ Modified Dandy criteria<ref name=JLSmith/> |-bgcolor="#EFEFEF" | 1 Signs & symptoms of increased ICP – CSF pressure >25 cmH2O |-bgcolor="#EFEFEF" | 2 No localizing signs with the exception of abducens nerve palsy |-bgcolor="#EFEFEF" | 3 Normal CSF composition |-bgcolor="#EFEFEF" | 4 Normal to small (slit) ventricles on imaging with no intracranial mass |} A 2002 review proposed a 6-point set of criteria that required no unexplained symptoms or signs, measurement of the CSF opening pressure in the lateral decubitus (i.e. lying on the side), exclusion of any other causes on specific forms of imaging.<ref name=FriedmanJacobson2002/> ==Pathogenesis== At least two primary mechanisms for the development of increased CSF pressure in primary IIH have been postulated: increased production of CSF and reduced resorption. Increased production may be the result of vasogenic extracellular brain edema, while decreased rebsorption may be due to low conductance of CSF outflow at the [[arachnoid granulation|arachnoid villi]].<ref name=Skau_et_al_2006>{{cite journal |author=Skau M, Brennum J, Gjerris F, Jensen R |title=What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment |journal=Cephalalgia |volume=26 |issue=4 |pages=384–99 |year=2006 |pmid=16556239 |doi=10.1111/j.1468-2982.2005.01055.x}}</ref><ref name=Sorensen_et_al_1989>{{cite journal |author=Sørensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O |title=Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion |journal=Neurol. Res. |volume=11 |issue=3 |pages=160–4 |year=1989 |pmid=2573851 |doi=}}</ref> ===Increased production=== Sørensen ''et al'' found evidence for increased water diffusion in the brain of IIH patients when compared to normal subjects.<ref name=Sorensen_et_al_1989/> It was argued that this evidence indicates abnormal convective transependymal water flow leading to brain edema. However, this theory remains controversial, as a similar study conducted by Bastin ''et al'' that used significantly disparate MR imaging protocols was unable to reproduce these findings.<ref name=Bastin_et_al_2003>{{cite journal |author=Bastin ME, Sinha S, Farrall AJ, Wardlaw JM, Whittle IR |title=Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study |journal=J. Neurol. Neurosurg. Psychiatr. |volume=74 |issue=12 |pages=1693–6 |year=2003 |pmid=14638893 |url=http://jnnp.bmj.com/cgi/content/full/74/12/1693 |doi=10.1136/jnnp.74.12.1693}}</ref> Normal CSF flow involves production at the [[choroid plexus]]es and absorption at the cranial and [[spinal nerve]] root arachnoid villi and granulations. ===Impaired CSF absorption=== Impaired CSF absorption at the [[superior sagittal sinus]] or along the spinal nerve roots could therefore explain IIH and has been documented in 75-100% of IIH patients.<ref name=Skau_et_al_2006/> Permeability along the blood-CSF barrier varies, producing an increasing [[oncotic pressure]] gradient between the CSF and venous system in a [[rostral]] to [[caudal]] progression.<ref name=Walker_2001>{{cite journal |author=Walker RW |title=Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? |journal=J. Neurol. Neurosurg. Psychiatr. |volume=71 |issue=1 |pages=1–5 |year=2001 |pmid=11413251 |url = http://jnnp.bmj.com/cgi/content/full/71/1/1 |doi=10.1136/jnnp.71.1.1}}</ref> It is speculated that variations in this oncotic pressure contribute to or impede CSF absorption. The mechanism remains unclear however, since high CSF protein concentrations, as commonly found in Guillain-Barré syndrome or spinal tumors, can manifest as intracranial hypertension, whereas individuals with IIH frequently present with normal-to-low CSF protein findings.<ref name=Skau_et_al_2006/> ==Treatment== The primary goal in treatment of IIH is the prevention of visual loss and blindness. IIH is treated mainly through the attempted reduction of CSF pressure and, where applicable, weight loss. IIH may resolve after initial treatment, may go into remission and relapse at a later stage, or may continue chronically.<ref name=FriedmanJacobson2002/> If the intracranial hypertension is secondary to medication, these need to be discontinued. ===Lumbar puncture=== CSF pressure may be temporarily decreased by repeated "therapeutic" (as opposed to diagnostic) [[lumbar puncture]]s (to remove excessive [[cerebrospinal fluid]]). However, this is generally regarded as a "holding measure" until medical or surgical treatment has been instituted.<ref name=FriedmanJacobson2002/><ref name=Curry_et_al_2005>{{cite journal |author=Curry WT, Butler WE, Barker FG |title=Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002 |journal=Neurosurgery |volume=57 |issue=1 |pages=97–108; discussion 97–108 |year=2005 |pmid=15987545| doi = 10.1227/01.NEU.0000163094.23923.E5 <!--Retrieved from CrossRef by DOI bot-->}}</ref> ===Medication=== The best studied medical treatment is the [[carbonic anhydrase]] inhibitor [[acetazolamide]], which reduces CSF production.<ref name=FriedmanJacobson2002/> Other drugs such as [[furosemide]] and various diuretics, and [[topiramate]] may be used in an attempt to reduce ICP. The long-term use of corticosteroids to treat chronic IH has fallen out of favor, unless there is a secondary inflammatory process caused by an underlying disease like lupus or Behcet disease. While corticosteroids may lower intracranial pressure in the short-term, the drawbacks to steroids include weight gain, fluid retention and a rebound in intracranial pressure during the drug’s withdrawal.<ref>{{cite web |url = http://www.ihrfoundation.org/intracranial/hypertension/info/C31 |title = IHRF Medication and Surgery}}</ref> ===Surgery=== Surgical treatments include optic nerve sheath decompression and fenestration. In this procedure, a slit is made in the sheath of the [[optic nerve]], which can alleviate swelling and slow or halt loss of vision.<ref>{{cite journal |author=Banta JT, Farris BK |title=Pseudotumor cerebri and optic nerve sheath decompression |journal=Ophthalmology |volume=107 |issue=10 |pages=1907–12 |year=2000 |pmid=11013197| doi = 10.1016/S0161-6420(00)00340-7 <!--Retrieved from CrossRef by DOI bot-->}}</ref> Optic nerve sheath fenestration is less effective in controlling the CSF pressure (and in controlling most symptoms, such as headache), but is more effective in protecting the optic nerve from the effects of pressure. Shunting is a [[neurosurgery|neurosurgical]] procedure to facilitate the drainage of excess CSF (thereby reducing ICP). A [[shunt (medical)|shunt]] is essentially a silicone tube inserted somewhere in the fluid spaces of the [[central nervous system]], which then drains CSF to the circulatory system or one of the body cavities. There are various types and configurations of shunts; ''lumboperitoneal'' (LP) shunts drain from the lumbar spine to the [[peritoneal cavity]], while ''ventriculoatrial'' (VA) shunts run from the cerebral ventricles to the [[heart]]. Although shunts can dysfunction due to occlusion, infection, malfunction, etc., they are very effective in normalizing CSF pressures. The absence of papilledema or longstanding symptoms make successful shunting less likely.<ref>{{cite journal |author=McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D |title=Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes |journal=J. Neurosurg. |volume=101 |issue=4 |pages=627–32 |year=2004 |pmid=15481717 |doi=}}</ref> Studies have shown that shunting procedures are becoming more common as the rate of severe obesity rises.<ref name=Curry_et_al_2005/> In cases of severe obesity, [[gastric bypass surgery]] has been shown to lead to a marked improvement in symptoms.<ref>{{cite journal |author=Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL |title=Gastric surgery for pseudotumor cerebri associated with severe obesity |journal=Ann. Surg. |volume=229 |issue=5 |pages=634–40; discussion 640–2 |year=1999 |pmid=10235521| doi = 10.1097/00000658-199905000-00005 <!--Retrieved from CrossRef by DOI bot-->}}</ref> ==Epidemiology== The reported annual incidence of IIH is <20 per 100,000 persons.<ref name=FriedmanJacobson2002/> ==History== The first report of IIH is usually ascribed to the German physician [[Heinrich Quincke]], who described it in 1893 under the name "serous meningitis".<ref>{{cite journal|author=Quincke HI|title=Meningitis serosa|journal=Samml Klin Vortr|year=1893|volume=67|pages=655}}</ref> The term "pseudotumor cerebri" was introduced in 1904 by [[Max Nonne]].<ref>{{cite journal|author=Nonne M|title=Ueber Falle vom Symptomkomplex "Tumor Cerebri" mit Ausgang in Heilung (Pseudotumor Cerebri)|language=German|journal= Dtsch Z Nervenheil|volume=27|pages=169–216|year=1904|doi=10.1007/BF01667111}}</ref> Diagnostic criteria were developed in 1937 by the [[Baltimore, Maryland|Baltimore]] neurosurgeon [[Walter Dandy]].<ref name=Dandy1937/><ref name="pmid16602675">{{cite journal |author=Johnston I |title=The historical development of the pseudotumor concept |journal=Neurosurg Focus |volume=11 |issue=2 | pages = 1 |year=2001 |pmid=16602675 |url=http://www.medscape.com/viewarticle/405734_1 | doi = 10.3171/foc.2001.11.2.3 <!--Retrieved from CrossRef by DOI bot-->}}</ref> ==References== {{reflist|2}} ==External links== * {{DMOZ|Health/Conditions_and_Diseases/Neurological_Disorders/Brain_Diseases/Intracranial_Hypertension/}} {{CNS diseases of the nervous system}} [[Category:Neurology]] [[de:Pseudotumor cerebri]] [[es:Hipertensión intracraneal]] [[nl:Pseudotumor cerebri]] [[sv:Idiopatisk intrakraniell hypertension]]